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An important aspect in the management of patients
with coronary artery disease (CAD) is consideration of
the duality of morphology and function.1 Hence, a
comprehensive assessment of CAD should include both
information on coronary lesion morphology and myo-
cardial perfusion, and ideally both should be obtained
noninvasively to allow for optimal clinical decision
making and reduce the risk inherent in invasive diag-
nostic procedures. While perfusion imaging has been
feasible by noninvasive means using myocardial perfu-
sion scintigraphy for more than 3 decades, the concept
of noninvasive coronary angiography has only recently
gained clinical acceptance by the introduction of mul-
tislice computed tomography (MSCT). The newer
generation CT scanners have finally met temporal and
spatial resolution requirements for clinical use and have
provided the base for combination with complementary
modalities into hybrid imaging.
Advances in image processing software and the
advent of hybrid scanners have further paved the way for
fusion of image data sets from different modalities. This
technology avoids mental integration of functional and
morphological images and facilitates a comprehensive
interpretation of the combined data sets. Particularly in
patients with CAD, by revealing the burden of anatomic
coronary disease and its physiologic relevance, the
hybrid approach can provide noninvasively unique
information that may help to improve diagnosis and
management. First pioneering attempts of image fusion
were promising2 but their widespread use was precluded
by issues of insufficient image resolution, the lack of
dedicated fusion software, and often tedious and time-
consuming image processing. Today, hardware and
software developments have significantly improved
hybrid imaging. Particularly, the creation of dedicated
fusion software packages that are now commercially
available have helped to simplify image fusion3 and
therefore facilitate its implementation in clinical prac-
tice. Thus, hybrid imaging is becoming more and more
available in specialized centers; however, data on its
clinical usefulness remain scarce.
In the present issue of the Journal of Nuclear
Cardiology, Santana et al4 report on their clinical
experience with hybrid imaging using 16- and 64-slice
CT angiography (CTA) and myocardial perfusion
imaging (MPI) with single photon emission computed
tomography (SPECT) or positron emission tomography
(PET) (the latter with 82-Rubidium) in a series of 50
patients. The use of fused images improved sensitivity
and particularly specificity for diagnosing significant
CAD compared to MPI alone and compared to the side-
by-side analysis of MPI and CTA. The reference stan-
dard was invasive coronary angiography (ICA) and
significant CAD was defined as at least one stenosis with
C50% obstruction. Although these single point statistics
failed to reach statistical significance the comparison of
diagnostic performance using receiver operating char-
acteristics (ROC) statistics yielded superiority of fusion
imaging over the other methods. This diagnostic impact
is further underscored by the fact that the fusion images
led to a modification of the initial interpretation in 28%
of the cases. Finally, the incremental value of hybrid
imaging compared to side-by-side analysis seemed to be
confined to patients with multivessel disease, where a
17% increase in sensitivity was noted.
With these important results Santana and coworkers5
build on existing experiences with hybrid imaging. The
present observations emphasize the incremental diag-
nostic value of hybrid imaging in several clinical
scenarios. On one hand, in low risk populations fusion
imaging increases the confidence for ruling out CAD as
reflected by the higher normalcy rate reported by Santana
et al. This is particularly helpful in a ‘‘stepwise’’ CAD
evaluation approach where the first study has yielded
equivocal results and a second study is needed to rule out
disease with final certainty. So far many of these patients
end up being referred for ICA, while hybrid imaging now
offers a substantially improved diagnostic confidence
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resulting in less equivocal findings which may allow to
greatly reduce the number of patients unnecessarily
exposed to the risks of invasive procedures.6 In patients
with multivessel disease, on the other hand, the use of
hybrid imaging may provide important comprehensive
evaluation. In fact, patients with multivessel disease who
usually are older than the population mentioned above,
have more jeopardized myocardium and impaired left
ventricular function as well as higher risk for cardio-
vascular events. The optimal appreciation of patients
with multivessel disease is therefore very important to
allow for timely and appropriate treatment. The use of
hybrid imaging in these patients may not only improve
diagnostic accuracy, but may also (by combination with
different tracers) enable evaluation of hemodynamic
relevance of coronary stenoses and assessment of via-
bility in territories subtended by occluded arteries.
Santana and colleagues demonstrate that particularly in
patients with multivessel disease the value of fusion
images lies beyond the simple addition of a further
diagnostic study. This value originates from the accurate
spatial association of perfusion defects and coronary
stenoses, which allows assigning hemodynamic proper-
ties to even small vessels, and is underscored by the 28%
rate of changes in diagnostic impression compared to the
side-by-side interpretation. Ultimately, this completely
noninvasive comprehensive approach to CAD allows to
obtain important information prior to any invasive pro-
cedure, and to stratify patients to their appropriate
treatment strategy.
An irritating problem when evaluating the diagnostic
performance of comprehensive hybrid technologies is the
lack of an appropriate gold standard. Although ICA is
widely accepted as the gold standard for CAD assessment
(and as such was used in the study by Santana et al) it
remains purely morphologic and lacks information on
hemodynamic severity of coronary lesions. Intrinsically,
when comparing a method for assessing coronary
morphology and myocardial perfusion (i.e., hybrid
technique) with a purely morphologic gold standard
(i.e., ICA) an imperfect match is unavoidable by nature
of the tests used. Conversely, the finding that adding
CTA to MPI improves accuracy is not surprising using
the gold standard of ICA, as a morphologic test com-
pares better to another morphologic test. For instance, if
an intermediate stenosis (i.e., 50-70% stenosis on ICA)
does not cause ischemia, it turns into a false negative
finding, although in fact this stenosis is most likely
hemodynamically irrelevant. By adding CTA which
then confirms an intermediate lesion this turns into a true
positive finding. Paradoxically, this contradicts the
wisdom that functional assessment is important and adds
important diagnostic information to CAD evaluation.
However, the incremental information is lost if the gold
standard is ICA. It is impossible that adding MPI to
CTA increases the clinical information if any informa-
tion from MPI is overruled by CTA. This conceptual
issue is the fundamental problem with diagnostic studies
using hybrid technology and future studies should aim at
using more complex or combined gold standards such as
for example ICA with fractional flow reserve measure-
ments or combination of ICA and nuclear techniques.
Ultimately, the best metric against which these tech-
niques will have to prove their validity will probably be
outcome and very recent data support that combined
noninvasive anatomical and functional assessment by
use of SPECT with CTA may allow improved risk
stratification.7
In conclusion, hybrid imaging combining nuclear
and CT has risen as a new and attractive cardiac imaging
modality. The improvements in software and hardware
have greatly simplified the use of this technique as
evidenced by the fact that in the study by Santana et al
different centers with different modalities (SPECT and
PET) and different generations of CT scanners (16- and
64-slices) were successful. This will help to further
promote its clinical application. However, many ques-
tions as to the real clinical usefulness of hybrid imaging
still remain unanswered and further research should aim
at assessing the impact of hybrid imaging on clinical
decision making and outcome. In the near future, hybrid
technology may play an important role in the assessment
and management of patients with heart disease due to its
comprehensive and noninvasive nature. Furthermore,
the unique potential to enable identification of high-risk
plaques using fusion of morphology and biology with
molecularly targeted PET imaging is a further—
although probably not so near—future perspective that
should encourage continuing research in this field.
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